[Concomitant use of nivolumab and immunosuppressants in a renal transplant patient].
Sign Up to like & getrecommendations! Published in 2019 at "Revue des maladies respiratoires"
DOI: 10.1016/j.rmr.2019.08.004
Abstract: INTRODUCTION Immune-checkpoint inhibitors have been approved for first and second line treatments of metastatic non-small cell lung cancer based on the results of several phase III trials. Patients with organ transplantation were excluded from these… read more here.
Keywords: nivolumab immunosuppressants; checkpoint inhibitors; use nivolumab; treatment ... See more keywords